← Back to Search

Imaging

Ventripoint Echocardiography for Single Ventricle Heart

N/A
Recruiting
Led By Piers Barker, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This trial will test a new echocardiogram technique to see if it accurately measures heart size and function in children and young adults with one working ventricle.

Who is the study for?
This trial is for children and young adults with a type of heart disease known as functional single ventricles. Participants can be any age and at any stage of surgical treatment, provided they are undergoing or have undergone a clinically ordered echocardiogram or cardiac MRI.Check my eligibility
What is being tested?
The study is testing the effectiveness of a new 3D echocardiographic technique called Ventripoint in assessing heart size and function compared to traditional transthoracic echocardiograms or cardiac MRIs in patients with single ventricle hearts.See study design
What are the potential side effects?
Since this trial involves non-invasive imaging techniques like echocardiograms and MRIs, there are minimal side effects expected. The most common issues might include discomfort from lying still during the procedure or mild anxiety related to medical equipment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiac function of the left ventricle as measured by ejection fraction
Cardiac function of the right ventricle as measured by ejection fraction
Left Ventricular Dimension as measured by end diastolic diameter
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ventripoint 3D EchocardiogramExperimental Treatment1 Intervention
Ventripoint 3D Echo performed on subject to validate technology for use in single ventricle patients.
Group II: Transthoracic Echocardiogram or Cardiac MRIActive Control1 Intervention
Non-invasive imaging of the heart to evaluate structure and function.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,375 Previous Clinical Trials
3,426,823 Total Patients Enrolled
Piers Barker, MDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity for individuals to sign up for this research?

"Data on clinicaltrials.gov shows that this medical trial is no longer recruiting patients, having been initially posted on March 1st 2022 and last updated February 21st 2022. However, 349 alternative studies are actively looking for participants to join their trials currently."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Duke University
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Ventripoint Single Ventricle Study
2022. "Ventripoint Single Ventricle Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05262907.
~39 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top